Type-specific stimulation of adenylylcyclase by protein kinase C
Ca(2+)-stimulable (type I), Ca(2+)-insensitive (type II), and Ca(2+)-inhibitable adenylylcyclase (type VI) were transiently expressed in the human embryonic kidney 293 cell line. Phorbol 12,13-dibutyrate (PDBu) increased cAMP synthesis by the Ca(2+)-insensitive type II adenylylcyclase more than 9-fo...
Saved in:
Published in | The Journal of biological chemistry Vol. 268; no. 7; pp. 4604 - 4607 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Bethesda, MD
American Society for Biochemistry and Molecular Biology
05.03.1993
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Ca(2+)-stimulable (type I), Ca(2+)-insensitive (type II), and Ca(2+)-inhibitable adenylylcyclase (type VI) were transiently
expressed in the human embryonic kidney 293 cell line. Phorbol 12,13-dibutyrate (PDBu) increased cAMP synthesis by the Ca(2+)-insensitive
type II adenylylcyclase more than 9-fold within 10 min, while the treatment had no effect on the other two types of adenylylcyclases.
This stimulatory effect of PDBu on type II activity was dose-dependent and synergistic with the effect of forskolin. Another
phorbol ester, phorbol 12-myristate 13-acetate (PMA), had a similar stimulatory effect on type II activity, while its inactive
isomer, 4 alpha-phorbol 12-myristate 13-acetate (4 alpha-PMA), had no effect. Staurosporine, a potent protein kinase C (PKC)
inhibitor, markedly attenuated the action of PDBu on cAMP synthesis by type II adenylylcyclase. These results are particularly
significant in that they indicate that a species of adenylylcyclase that is insensitive to regulation by one arm of the phosphatidylinositide
pathway, i.e. Ca2+, nevertheless can be regulated by the other arm, i.e. PKC. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1016/s0021-9258(18)53439-6 |